EXPLANATORY WORKSHOP
On May 9, 2022 an Explanatory Workshop was organized to clarify any doubts that had arisen regarding the documentation bidders have to prepare for the tender.
More than 120 attendees asked about the process, financial details, consortia building, open platform, subcontracting, award criteria and much more.
EXPLANATORY WORKSHOP on ROSIA´s call for tender
Both ROSIA’s presentation and the subsequent Q&A session (split into clips per question) are available for download from ROSIA’s website.
All Q&As have been transcribed and posted in the Spanish Public Procurement Platform, which is also the channel potential bidders are invited to use in submitting any pending questions.
PDF Presentation
ROSIA Description by Alli McClean
Q1
Workshop recording availability.
Q2
Do consortia need to be definitively consolidated when submitting a tender, or can they be altered later on?
Q3
Are there any geographic restrictions for consortia in terms of members belonging or not to the EU?
Q4.1
Do each of the procuring entities have a different set of rehabilitation categories they are trying to tackle, or have they come together and agreed on a single range of categories?
Q4.2
Are the funds for each phase to be split between the members of bidding consortia?
Q5
By open platform, do you mean a set of software that integrates with as many applications as possible (such as an SDK easily managed by different users) or are you referring to an open-sourced platform?
Q6
Is there a possibility to obtain feedback regarding the quality of the exercises proposed in rehab programmes?
Q7.1
How are companies selected after each phase of the PCP process?
Q8
Are there any requirements regarding connectivity with external hardware and applications? And are all of these supposed to be connected in a central way through a gateway or application to transfer the information to the cloud?
Q9.1
What is meant by an Open Platform?
Q9.2
Does the term “open” not clash with issues such as licensing of proprietary software developed by bidders?
Q11
Is the development of microservices a mandatory requirement regarding the architecture of the platform?
Q12
Are bidders expected to have the cloud platform already developed in Phase I?
Q13
How are solutions measured in terms of effectiveness?
Q14
What kind of sensors are bidders expected to implement in the remote monitoring of patients?
Q15
If more than 5 bidding consortia are accepted in Phase I, does that mean that the total allotted 100k for Phase I is shared among them all, each receiving therefore an amount lower than 20k?
Q16
Can bidders subcontract services or technologies included in their bid?
Q17
Is it the objective of ROSIA to end up with one single solution – one single platform?
Q18
Under the EU GDPR, is the open platform considered a data controller?
